Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) was $7.44 for the day, up 5.83% from the previous closing price of $7.03. In other words, the price has increased by $5.83 from its previous closing price. On the day, 0.92 million shares were traded. BCYC stock price reached its highest trading level at $7.7374 during the session, while it also had its lowest trading level at $6.935.
Ratios:
Our analysis of BCYC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.86 and its Current Ratio is at 14.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $25.
On September 06, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $35.
B. Riley Securities Downgraded its Buy to Neutral on August 07, 2024, whereas the target price for the stock was revised from $33 to $28.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 02 ’25 when Young Alethia bought 206 shares for $7.09 per share.
Thompson Travis Alvin bought 530 shares of BCYC for $3,760 on Jul 02 ’25. On Jul 02 ’25, another insider, Hannay Michael Charles Ferguso, who serves as the Officer of the company, bought 756 shares for $7.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCYC now has a Market Capitalization of 515249056 and an Enterprise Value of -303333088. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.99 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at -11.793 whereas that against EBITDA is 1.258.
Stock Price History:
The Beta on a monthly basis for BCYC is 1.43, which has changed by -0.6318654 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, BCYC has reached a high of $28.67, while it has fallen to a 52-week low of $6.10. The 50-Day Moving Average of the stock is -8.74%, while the 200-Day Moving Average is calculated to be -48.31%.
Shares Statistics:
BCYC traded an average of 343.50K shares per day over the past three months and 371110 shares per day over the past ten days. A total of 69.20M shares are outstanding, with a floating share count of 61.47M. Insiders hold about 11.18% of the company’s shares, while institutions hold 57.30% stake in the company. Shares short for BCYC as of 1749772800 were 2483120 with a Short Ratio of 7.23, compared to 1747267200 on 3329010. Therefore, it implies a Short% of Shares Outstanding of 2483120 and a Short% of Float of 6.84.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
